# Taste Assessment of Ozanimod

> **NCT05001152** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 7 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Ozanimod

## Key facts

- **NCT ID:** NCT05001152
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-09
- **Primary completion:** 2021-09-17
- **Final completion:** 2021-09-27
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05001152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05001152, "Taste Assessment of Ozanimod". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05001152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*